GT
Guided Therapeutics, Inc.
GTHP · OTC
$0.25 -0.80% (-$0.00)
1M +10.22%
Market Cap $23.9M
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 36.83x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 289.30%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 573.08%
Op. margin 337.23%
FCF margin 231.69%
Quality
10 /100
Poor ROA 311.72%
Asset turnover 0.54x
ROIC 83.51%
Debt
0 /100
High Int. coverage -4.41x
Current ratio 0.09x
Net debt/EBITDA N/A
Stability
49 /100
Moderate Rev. volatility 6,117.83%
EPS volatility 23.49%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GTHP
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mark L. Faupel
Employees
3
Headquarters
Peachtree Corners